Danish drugmaker Novo Nordisk (NVO) reported fourth quarter and full 12 months 2024 earnings Wednesday, beating Wall Road's expectations and bumping its fill up greater than 3% in pre-market buying ...
Unlock the Editor’s Digest without costRoula Khalaf, Editor of the FT, selects her favorite tales on this weekly e-newsletter.The greenback rose to its highest degree in additional than two years ...
Keep knowledgeable with free updatesMerely signal as much as the US rates of interest myFT Digest -- delivered on to your inbox.The Federal Reserve reduce its benchmark rate of interest ...
